Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Fibrogen Inc CS (NQ: FGEN ) 0.3920 -0.0074 (-1.85%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Fibrogen Inc CS < Previous 1 2 3 4 5 6 7 8 9 10 Next > FibroGen's Return on Invested Capital Overview May 23, 2023 Via Benzinga FibroGen's Anemia Candidate Fails In Myelodysplastic Syndrome Study May 05, 2023 Via Benzinga FibroGen Earnings Preview May 05, 2023 Via Benzinga Why did Sarepta Therapeutics Stock Plummet? March 21, 2023 SRPT stock fell 20% after the FDA changed course on their new DMD treatment approval. The stock remains strong with an encouraging outlook and a mod Buy rating. Via MarketBeat Exposures Product Safety FibroGen's Return On Capital Employed Insights March 02, 2023 Via Benzinga Analyst Ratings for FibroGen February 28, 2023 Via Benzinga FibroGen Shares Gain As Analyst Creates Bullish Pitch On Pulmonary Fibrosis Opportunity January 31, 2023 Via Benzinga B of A Securities Upgrades FibroGen: Here's What You Need To Know January 05, 2023 Via Benzinga Short Volatility Alert: FibroGen, Inc. August 31, 2022 On Tuesday, shares of FibroGen, Inc. (NASDAQ: FGEN) experienced volatile short activity. After the activity, the stock price went down -4.38% to $12.87. The overall sentiment for FGEN has been... Via Benzinga Recap: FibroGen Q2 Earnings August 08, 2022 FibroGen (NASDAQ:FGEN) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Via Benzinga Earnings Scheduled For February 27, 2023 February 27, 2023 Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million. Via Benzinga Earnings Preview For FibroGen February 24, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2023 January 31, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2023 January 26, 2023 Via Benzinga Perrigo, Tripadvisor, Lyft, And Some Other Big Stocks Moving Lower On Tuesday November 08, 2022 U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Tuesday. Here are some big stocks recording losses in today’s session. Via Benzinga Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session January 05, 2023 Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization... Via Benzinga FibroGen Earnings Preview November 04, 2022 FibroGen (NASDAQ:FGEN) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that FibroGen will report... Via Benzinga 7 Unknown Biotech Stocks That Could Rocket in 2023 September 23, 2022 Unknown biotech stocks that are poised for a big rally in 2023. Emerging biotech companies with a promising clinical pipeline. Via InvestorPlace Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 January 05, 2023 Via Benzinga Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday November 09, 2022 Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday. Via Benzinga Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session November 08, 2022 Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast... Via Benzinga Recap Of Friday's Biotech Catalysts - End Of the Day Summary August 26, 2022 Via Benzinga FibroGen Concludes Dosing In Late-Stage Blood Cell Disorder Study, Sees Top-line Data In H1 2023 August 26, 2022 FibroGen, Inc. (NASDAQ: FGEN) has completed patient enrollment for MATTERHORN, a Phase 3 clinical study of roxadustat for treatment of anemia in patients with lower risk transfusion-dependent... Via Benzinga FIBROGEN INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Provides Update of its Investigation of the Officers and Directors of FibroGen, Inc. - FGEN August 19, 2022 From Kahn Swick & Foti, LLC Via Business Wire Preview: FibroGen's Earnings August 05, 2022 FibroGen (NASDAQ:FGEN) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors need to know before the announcement. Analysts estimate that FibroGen will report... Via Benzinga FIBROGEN INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Provides Update of its Investigation of the Officers and Directors of FibroGen, Inc. - FGEN July 22, 2022 From Kahn Swick & Foti, LLC Via Business Wire Akebia Therapeutics (AKBA) Stock Soars 18% Despite Lack of News June 29, 2022 AKBA stock is up big, but the lack of news is concerning considering that Akebia Therapeutics already faces a regulatory setback. Via InvestorPlace FibroGen, Inc. (NASDAQ:FGEN) Investor Alert: Investigation over Potential Wrongdoing June 24, 2022 San Diego, CA -- (SBWIRE) -- 06/24/2022 -- An investigation was announced for current long-term investors in shares of FibroGen, Inc. (NASDAQ:FGEN) over potential breaches of fiduciary duties by... Via SBWire FIBROGEN INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of FibroGen, Inc. - FGEN May 27, 2022 From Kahn Swick & Foti, LLC Via Business Wire 103 Biggest Movers From Yesterday May 11, 2022 Gainers Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.